Home > Healthcare > Pharmaceuticals > Finished Drug Form > Opioid Use Disorder Market
Opioid Use Disorder Market Size
- Report ID: GMI5838
- Published Date: May 2023
- Report Format: PDF
Opioid Use Disorder Market Size
Opioid Use Disorder (OUD) Market size was estimated to be USD 2.8 billion in 2022 and is expected to expand at CAGR of 10.6% from 2023 to 2032. Rise in drug approvals for the treatment of opioid use disorder, increasing opioid addiction cases in developed counties, and increasing awareness for the adoption of buprenorphine patches as an effective treatment are some of the key factors driving this market.
The number of opioid addiction cases are rapidly rising every year and making opioid dependence a serious public health issue. Opioid use disorder (OUD) is a treatable, chronic disease that can affect anyone regardless of race, gender, income level, or social class. Opioids are natural, semi-synthetic, or synthetic chemicals that interact with opioid receptors in the body and brain and reduce perception of pain. Prescription opioids are meant to be used to treat acute pain (such as recovering from injury or surgery), chronic pain, active-phase cancer treatment, palliative care, and end-of-life care.
| Report Attribute | Details |
|---|---|
| Base Year: | 2022 |
| Opioid Use Disorder Market Size in 2022: | USD 2.8 Billion |
| Forecast Period: | 2023 to 2032 |
| Forecast Period 2023 to 2032 CAGR: | 10.6% |
| 2032 Value Projection: | USD 7.5 Billion |
| Historical Data for: | 2018 to 2022 |
| No. of Pages: | 243 |
| Tables, Charts & Figures: | 423 |
| Segments covered: | Drug Type, Age Group, Route of Administration, Distribution Channel, and Region |
| Growth Drivers: |
|
| Pitfalls & Challenges: |
|
Frequently Asked Questions (FAQ) :
Opioid Use Disorder Market Scope
